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Abstract
A role for the cerebellum in causing ataxia, a disorder characterized by uncoordinated movement, 
is widely accepted. Recent work has suggested that alterations in activity, connectivity, and 
structure of the cerebellum are also associated with dystonia, a neurological disorder characterized 
by abnormal and sustained muscle contractions often leading to abnormal maintained postures. In 
this manuscript, the authors discuss their views on how the cerebellum may play a role in dystonia. 
The following topics are discussed:
• The relationships between neuronal/network dysfunctions and motor abnormalities in 
rodent models of dystonia.
• Data about brain structure, cerebellar metabolism, cerebellar connections, and 
noninvasive cerebellar stimulation that support (or not) a role for the cerebellum in 
human dystonia.
• Connections between the cerebellum and motor cortical and sub-cortical structures that 
could support a role for the cerebellum in dystonia.
Overall points of consensus include:
• Neuronal dysfunction originating in the cerebellum can drive dystonic movements in 
rodent model systems.
• Imaging and neurophysiological studies in humans suggest that the cerebellum plays a 
role in the pathophysiology of dystonia, but do not provide conclusive evidence that 
the cerebellum is the primary or sole neuroanatomical site of origin.
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Introduction
Dystonia is a neurological disorder characterized by sustained involuntary muscle 
contractions, which distort the body into abnormal postures. These muscle contractions can 
also sometimes cause abnormal, repetitive movements, often initiated or worsened by 
voluntary action and associated with overflow muscle activation [1]. Dystonias may be 
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classified based on clinical characteristics or etiology. Clinically, dystonia may affect only 
one body region or may be more generalized [1]. Spontaneous genetic mutations and 
pharmacological manipulations in animals can produce abnormal movements that resemble 
human dystonia. Although the mechanism for these movements in animals may sometimes 
be disparate from the human disorder, it is helpful to study these movements in animals to 
derive possible mechanistic information regarding the etiology of human dystonia. For the 
purpose of this review, dystonia in both humans and animals is defined by the characteristic 
phenotype of abnormal, repetitive movements which distort the body into abnormal 
postures.
Movement in mammals is a result of coordinated activity of multiple areas of the nervous 
system, ultimately converging on muscles that are under the control of motor neurons in the 
spinal cord and brainstem. Although all these systems are interconnected, abnormalities in 
distinct nodes or anatomical regions of the nervous system are likely responsible for distinct 
movement disorders such as dystonia.
The basal ganglia represent one such node; dystonia is traditionally viewed as a disorder of 
the basal ganglia [2], but recent evidence suggests that other nodes in the motor network 
may also contribute to dystonia [3]. These observations have led to speculation that dystonia 
may arise from different types of defects within the motor network [4]. It may arise from 
dysfunction of a single node in the network, simultaneous dysfunction of more than one 
node, or abnormal communication between the nodes. One such additional node that has 
recently been implicated in dystonia is the cerebellum.
In this manuscript, animal studies linking the cerebellum to dystonia are summarized. This is 
followed by a summary of the role of the cerebellum in human dystonia. A consensus 
opinion of the role of the cerebellum in dystonia is presented, in addition to areas for future 
research.
Motor Pathways Involved in Dystonia (H.A. Jinnah, Yoland Smith, Ellen 
Hess)
Some of the strongest evidence for involvement of nodes other than the basal ganglia in 
dystonia has come from animal studies and, particularly, rodents. This evidence must be 
interpreted in view of potential species differences.
Species Differences in Motor Behavior
The normal motor behavior of humans and rodents is quite different, so the first question to 
address is whether or not dystonia can occur in rodents. Dystonia is defined by the quality of 
abnormal movements, with excessive contraction of muscles that lead to twisting or 
repetitive movements or postures [1]. By definition, any abnormal movements with these 
qualities are “dystonic”. Co-contraction of antagonistic muscle pairs is said to be 
characteristic of dystonia, but this phenomenon is not universal [5]. Electromyography can 
be helpful in confirming some of the electrophysiological correlates of these movements [6], 
but the results are not required for diagnosis because they are neither sensitive nor specific 
for dystonia.
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The spontaneous occurrence of dystonic movements also has been reported in the veterinary 
literature for many other species including farm animals such as horses and chickens, other 
domestic animals such as dogs and cats, and wild birds. Dystonic movements have been 
reported following a variety of manipulations in different experimental animals including 
non-human primates [7], cats, and rodents [8, 9]. Many of these studies include careful 
descriptions of abnormal movements, often with accompanying video demonstrations that 
fulfill currently accepted clinical criteria for “dystonia” [8, 9]. Thus, dystonic movements are 
not unique to humans.
Some critics of animal models argue that the abnormal movements seen in rodents may be a 
“phenocopy” of dystonia and not “real” dystonia. Unfortunately, this argument is invalid 
because the concept of a “phenocopy” is meaningless when a disorder is defined by its 
phenotype. The more relevant concern is whether the biological mechanisms responsible for 
the same phenotype are similar in humans and rodents. Because these mechanisms are 
poorly understood, this question remains open.
Species Differences in Anatomical Pathways
The normal nervous system of rodents and humans is quite different, so one important 
question to address is whether the anatomical structures and pathways causing dystonia 
differ across species. For the motor system, the most obvious species differences are at the 
gross structural level [10]. For example, the rodent brain is clearly much smaller. All three 
major motor control nodes are clearly recognizable in rodents, but within each region there 
are again some visible differences. However, beyond these superficial differences in gross 
appearance, there are many similarities across species at the synaptic, cellular, and molecular 
levels.
Motor Cortex—Grossly, the rodent motor cortex is smooth, unlike humans where there are 
prominent sulci and gyri. The rodent “primary motor” cortex is made up of M1 and M2 
subareas that are poorly demarcated from each other, whereas in humans, there are clear 
functional subdivisions into primary motor, ventral and dorsal pre-motor, supplementary 
motor, cingulate motor, and other related cortices. Cytoarchitechtonically, the laminar 
structure of the rodent motor cortex is simpler than in humans. However, the various 
neuronal subtypes and their general morphology are grossly similar between rodents and 
humans. Most notable are the large pyramidal neurons that project to motor neurons in the 
brainstem and spinal cord, and others that project to the basal ganglia or cerebellum. All of 
these pathways use the excitatory transmitter glutamate in both species, and post-synaptic 
signal transduction mechanisms are likely to be the same in rodents and humans. However, 
there are some significant differences in the extent of direct interactions between 
corticospinal axons and motoneurons. Although direct cortico-motoneuronal connections are 
a predominant feature in primate species including humans, they do not exist in rodents and 
carnivore species [11]. This evolutionary feature likely subserves new aspects of fine motor 
control, including manual dexterity in humans, an issue of importance in some forms of 
focal dystonia.
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Basal Ganglia—Like the motor cortex, the basal ganglia are less structurally demarcated 
in rodents compared to humans. For example, the caudate nucleus and putamen are separate 
in humans, but merged into a single structure called the caudoputamen in rodents. In 
addition, rodents do not have an internal globus pallidus like humans; the rodent homolog is 
the entopeduncular nucleus, which has some similarities, but also some differences in cell 
types and projections compared to the human internal pallidum. Further, the human basal 
ganglia are functionally and somatotopically organized from the input stage through 
thalamocortical outputs. This topography is less obvious in rodents.
Despite these gross anatomical differences between humans and rodents, the intrinsic 
circuitry of the basal ganglia is strikingly similar across species, with both direct, indirect 
and hyperdirect subcortical pathways. The major afferent and efferent pathways also are 
similar, although the relative importance of individual pathways may vary. Robust striatal 
afferents come from the cerebral cortex, thalamus, substantia nigra, and other areas. Key 
efferents exit through thalamocortical connections or descending brainstem projections. 
Histologically, the appearance and relative abundance of cell types in the striatum are 
strikingly similar in rodents and humans with medium spiny neurons projection neurons 
constituting 90 % of the neurons and a smaller number of interneurons. Functional 
properties of striatal neurons are also preserved across species as diverse as lampreys to 
mammals [12]. Finally, the chemical anatomy of the rodent and human basal ganglia is 
similar. The same neurotransmitter are used by all of the major basal ganglia afferents 
(glutamate, dopamine, acetylcholine, norepinephrine, and serotonin), intrinsic connections 
(glutamate, GABA, acetylcholine, and adenosine), and efferents (mostly GABA).
Cerebellum—The gross anatomy of the rodent cerebellum is different from humans; it is 
smaller with relatively less prominent hemispheres. However, the major efferent and efferent 
connections are similar in rodents in humans, with entry and exit through three very similar 
peduncles. Once again, however, the relative contribution of afferent and efferent pathways 
differs between rodents and humans. The cytoarchitectonics are strikingly similar across 
species with a cerebellar cortex divided into 3 layers (molecular layer, Purkinje layer, and 
granule layer) and distinct cerebellar nuclei deep in the white matter (dentate, globose, 
fastigial, and emboliform). The intrinsic circuitry of the cerebellum also is identical across 
species, with a highly characteristic layout of climbing fibers, mossy fibers, parallel fibers, 
and Purkinje neuron output.
Are Species Differences Relevant for Dystonia?
With regard to both motor behavior and neuroanatomy, there are clear differences between 
rodents and humans that must be acknowledged. Regarding motor behavior, some subtypes 
of dystonia such as writer’s cramp may not occur in rodents, but there is no reason to suspect 
that other types of dystonia do not occur. Regarding the neuroanatomy, species differences 
are obvious, but the similarities are more extensive. The critical issue is not whether there 
are differences between humans and rodents, but whether these differences are sufficiently 
critical to dismiss the rodent literature. The answer to this question is unknown. However, 
there is presently no clear evidence that dystonia in rodents and humans is mediated by 
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different anatomical pathways. Instead, the more parsimonious working hypothesis is that 
these pathways are biologically similar.
The continuing debate regarding the potential relevance of species differences is not 
constructive to the future research mission because it promotes the view that we must be 
skeptical of results obtained from rodents until these differences can be conclusively 
resolved. These differences will never be resolved. If this skepticism is allowed to guide 
future experimental strategy, then we must also begin to question results from Drosophilia 
melanogaster, Caenorhabditis elegans, and other common experimental models. For these 
models, species differences are even larger. A further extension of this line of thinking is that 
tissue culture models also are invalid. An experimental toolkit for dystonia that involves only 
in vivo studies of primates profoundly limits the types of studies that can be conducted. This 
overly restrictive philosophy is not applied to other neurological disorders such as 
Parkinson’s disease, Alzheimer’s disease, or epilepsy. It therefore should not be applied in 
dystonia research, unless there is evidence that rodent experiments lead to results that are 
misleading for human dystonia.
Rather than dismiss potentially valuable novel insights from these simpler experimental 
models, a more productive approach is to explore the relevance of any findings from these 
other models in humans (Fig. 1a), or at least non-human primates (Fig. 1b). The ultimate 
proof of the value of simpler experimental models is how effectively they can guide studies 
of human dystonia. In fact, studies in humans based on novel insights from these simpler 
models have already begun to emerge. The majority of these studies so far appear to confirm 
the concept originating from animal work that dystonia is a motor network disorder that is 
not due exclusively to defects in the basal ganglia [4, 13–17].
The Cerebellum and Primary Dystonia: What Do Rodent Models Based on 
Human Dystonia Genes Tell Us? (William Dauer)
Modeling dystonia by recapitulating the disease in animal models is an important and 
appealing approach to understanding the neural basis of the disease, yet pitfalls and land 
mines abound. First, what behavior constitutes dystonia in a rodent? The difficulty in 
answering this question becomes apparent when one considers that the movement disorder 
community recently felt necessary to update the definition of dystonia in humans [1], and 
the frequent disagreements between clinicians as to whether or not the abnormal movements 
of certain patients constitute dystonia. There are examples of dystonic-appearing movements 
in rodents that arise from derangements of CNS regions not thought relevant to human 
dystonia [18], highlighting the danger of relying exclusively on a behavioral definition in an 
experimental model. Challenges in dystonia research arise to a considerable degree because 
there is no test that definitively identifies movements as dystonic; even if we accept a 
working definition of dystonia as any abnormal twisting movement (as done in this review), 
it remains uncertain which of these “dystonias” in rodents is consequent to mechanisms 
causing human dystonia. Co-contraction of agonists and antagonists is frequently used as an 
electrophysiological definition, but this feature is non-specific, occurring in several 
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movement disorders, and in normal people (try making a tight fist, and you will quickly 
appreciate the co-contraction of the forearm flexors and extensors).
One way to potentially circumvent these difficulties is to begin with an etiological insult that 
causes dystonia in humans—mutant genes for primary dystonia. However, because the 
organization of the rodent and human CNS differs—including the organization of the basal 
ganglia and related pathways—a molecular lesion that causes dystonia in humans could, in 
principal, produce a distinct behavioral abnormality in rodents. For example, lesions of the 
subthalamic nucleus cause hemiballism in humans, but not in rodents. This issue is 
eloquently discussed in detail in an opinion article by Tim Schallert and colleagues [19] 
where they state, “The first question to ask is not whether a rat would show a given 
neurological symptom, but rather, how that neurological symptom would manifest itself in a 
rat.”
Based on these considerations, I will review published data that implicate the cerebellum in 
the genesis of any motor abnormalities caused by the manipulation of human primary 
dystonia genes. All such data come from studies of the DYT1 mutation (“ΔE”) in the 
dystonia gene TOR1A that encodes the protein torsinA.
Establishing the involvement of a brain structure (or cell type) in a behavior requires careful 
analysis of the necessity and sufficiency of that structure for the behavior. In the context of 
primary dystonia, this means demonstrating that the genetic insult (torsinA loss of function) 
selectively within the cerebellum disrupts motor function (sufficiency), and that torsinA-
related cerebellar dysfunction is necessary to disrupt motor behavior. There are data 
demonstrating that some cerebellar cell types are sensitive to torsinA loss of function. 
However, no data exists that establish a role for these cells, or the cerebellum generally, in 
torsinA-related motor dysfunction.
Tor1aΔE/+ mice, the genetic phenocopy of the human disease, exhibit little [20] or no [21] 
motor phenotype, but show abnormalities of cerebellar metabolism [22]; the role, if any, of 
these areas in creating motor dysfunction was not addressed. A broad neuropathological 
assessment of these animals, including the cerebellum, identified only subtle microstructure 
abnormalities of striatal projection neurons [23]. Several models exhibit overtly abnormal 
twisting behaviors, including conditional deletion of Tor1a from the CNS or midbrain/hind-
brain, or selective expression of ΔE-torsinA in these two patterns [24]. These models also 
show striking degeneration of deep cerebellar nuclear (DCN) neurons, but no morphological 
abnormalities of other cerebellar cell types. Selective expression of the Tor1aΔE/+ genotype 
in the midbrain/hindbrain region similarly does not disrupt motor behavior in any overt way 
[25]. These data demonstrate that within the cerebellum, DCN neurons are uniquely 
sensitive to torsinA loss of function, but do not establish the necessity or sufficiency of these 
cells for the abnormal behavior.
In contrast to these data, conditional deletion of Tor1a from forebrain cholinergic and 
GABAergic neurons [26], or from striatum or cortex [27, 28] all cause motor dysfunction. 
These models suggest that torsinA-related cerebellar abnormalities are not necessary for 
torsinA-related motor dysfunction.
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There are several caveats and qualifications to the above analysis, which cannot be addressed 
in this short format. Perhaps most important is the question of whether focusing on a single 
structure as a dystonia “cause” is the right approach for a phenomenon that appears to be a 
network disorder that can be provoked by insults to several motor areas [29] or when the 
function of a structure is altered: Does the resulting behavior derive from that structure or 
compensation from other brain regions? Developing an improved conceptual construct of 
what constitutes dystonic behavior, and the CNS circuit abnormalities that are likely to drive 
such behavior, seems essential.
Anatomical Pathways for Cerebellar Contributions to Dystonia (Andreea 
Bostan and Peter Strick)
Here, we discuss the substantial anatomical connections in nonhuman primates that identify 
potential routes for interactions between the cerebellum and basal ganglia in the 
manifestation of dystonia.
The cerebellum and basal ganglia have long been recognized for contributions to the control 
of movement through influence on the primary motor cortex (M1). More recently, 
experiments using neurotropic viruses as transneuronal tracers in nonhuman primates have 
demonstrated that cerebellar and basal ganglia outputs reach not only M1, but also premotor, 
prefrontal, and parietal areas [30]. Cerebellar output channels to M1 and premotor areas 
cluster in dorsal regions of the cerebellar dentate, identifying a motor domain within this 
nucleus [31]. A motor domain has also been identified in the internal segment of the globus 
pallidus (GPi), a major output nucleus of the basal ganglia [32]. In general, the ratio of basal 
ganglia to cerebellar input to a motor area is 1:1, i.e., a cortical motor area is the target of 
output from equal numbers of basal ganglia and cerebellar output neurons. The one 
exception to this pattern is the supplementary motor area, in which the ratio of basal ganglia 
to cerebellar output is approximately 3:1 [32]. Clearly, the motor domains of the cerebellum 
and basal ganglia provide substantial input to each of the cortical motor areas and, thus, can 
have a significant influence over their function.
As the outputs from the cerebellum and basal ganglia to the cerebral cortex are relayed 
through separate thalamic nuclei, any interactions between cerebellar and basal ganglia 
loops with the cerebral cortex were thought to occur at the level of the cerebral cortex [33]. 
Results from recent anatomical experiments in nonhuman primates challenge this 
perspective and provide evidence for disynaptic pathways that link the cerebellum with the 
basal ganglia more directly (Fig. 2). Transneuronal transport of rabies virus demonstrated 
that the dentate nucleus projects, via the intralaminar thalamic nuclei, to the striatum and 
then to the external segment of the globus pallidus (GPe) [34]. Projections originate from 
both motor and nonmotor domains of the dentate and may influence both motor and 
nonmotor functions within the basal ganglia. Remarkably, the number of dentate neurons 
that target localized portions of the GPe is comparable to the number of dentate neurons that 
reach areas of cerebral cortex [34], emphasizing the functional relevance of cerebellar 
influences on basal ganglia activity. Indeed, studies in mice found that cerebellar stimulation 
alters activity in about half of striatal neurons and can affect cortico-striatal plasticity, via the 
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disynaptic cerebello-thalamo-striatal pathway. Furthermore, under pathological conditions, 
this pathway can transmit abnormal cerebellar activity to the basal ganglia, resulting in 
dystonic movements [35].
In a different series of anatomical experiments, virus transport demonstrated that the 
subthalamic nucleus (STN) projects disynaptically to the cerebellar cortex (Fig. 2) [36]. 
Projections to the cerebellar cortex originate from motor and nonmotor domains within the 
STN [36].These inputs terminate in motor and nonmotor regions of the cerebellar cortex 
and, thus, enable basal ganglia activity to affect multiple functional domains of the 
cerebellum. The numbers of STN neurons that target a specific site within the cerebellar 
cortex are comparable to the numbers of STN neurons that influence areas of the cerebral 
cortex (e.g., M1; see [37]). This result emphasizes the functional relevance of the STN 
influence on cerebellar activity. Indeed, deep brain stimulation of the STN in rats can alter 
activity of cerebellar neurons [38].
Overall, the results from neuroanatomical studies in non-human primates indicate that basal 
ganglia and cerebellar outputs converge at the level of the cortical motor areas. In addition, 
our new results demonstrate that basal ganglia and cerebellar circuits with the cerebral 
cortex are massively interconnected at the subcortical level. In an output stage of cerebellar 
processing, the dentate nucleus is disynaptically linked to the input stage of basal ganglia 
processing, the striatum. Similarly, an output stage of basal ganglia processing, the STN, is 
disynaptically linked to the input stage of cerebellar processing, the cerebellar cortex. These 
interconnections suggest that the cerebellum and basal ganglia are more functionally 
interdependent than previously suspected. Furthermore, these interconnections allow for 
abnormal activity in the cerebellum to alter basal ganglia function and vice versa. This new 
perspective suggests that disorders typically associated with the basal ganglia, such as 
dystonia, are best understood as disorders of an integrated network that includes the basal 
ganglia, cerebellum, and the motor cortical areas.
How Does the Cerebellum Fit into the Functional Neuroanatomy of Dystonia 
in Mouse Models? (Robert Raike, H.A. Jinnah, and Ellen Hess)
Although imaging studies in humans have proven invaluable for providing evidence of 
abnormalities in patients, the results are often correlative, so it is difficult to distinguish 
cause from consequence. Therefore, animal models, oftentimes mouse models, have been 
used to facilitate our understanding of the role of the cerebellum in dystonia. Abnormal 
cerebellar activity is observed in many different mouse models of generalized dystonia. 
Genetically engineered mouse models of Dyt1 dystonia exhibit an increase in metabolic 
activity within the cerebellum and expression of the immediate early gene c-fos, a reliable 
reporter of changes in neuronal activity is observed in the cerebellum of tottering mice, 
which exhibit episodes of generalized dystonia caused by a defect in the Cav2.1 calcium 
channel [39] [22, 40]. Further, abnormal Purkinje cell firing rates are associated with 
generalized dystonia in tottering mice, mouse models of rapid-onset dystonia parkinsonism 
(RDP), and IPCR1 (inositol 1,4,5-triphosphate receptor type 1) deficit mice. In all of these 
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models, the abnormal Purkinje cell activity correlates with the abnormal body movements 
[41–44].
Eliminating cerebellar output abolishes the generalized dystonia in mouse models of 
dystonia, suggesting that the cerebellum is a critical node in the pathway leading to the 
expression of dystonia [45, 46]. Surgical removal of the cerebellum eliminates generalized 
dystonia in tottering mice, lesioning the deep cerebellar nuclei reduces the dystonic 
movements in RDP mice, and the progressive cerebellar degeneration observed in leaner 
mice, another calcium channel mouse mutant, is associated with a significant amelioration in 
their severe generalized dystonia [47] [48, 49]. Similarly, pharmacological inactivation of 
the cerebellum ameliorates the dystonia in RDP mice and IPCR1 deficit mice [44, 47]. 
Further, genetic deletion of Purkinje cells, the only efferents of the cerebellar cortex, using 
toxic transgenes or mutations abolishes dystonia in the tottering mutant and IPCR1 deficit 
mice [44, 45, 50]. While these cerebellar lesion and inactivation experiments suggest that 
cerebellar signaling is necessary for the expression of dystonia in these models, such 
experiments cannot determine whether the cerebellum actually causes the dystonia.
Mouse models have been used to establish a causal relationship between cerebellar 
dysfunction and dystonia by experimentally disrupting cerebellar signaling to instigate 
dystonia. Pharmacological induction of abnormal cerebellar signaling through the 
intracerebellar administration of AMPA receptor agonists or ouabain, an inhibitor of the 
Na+/K+ ATPase ion pump, induces generalized dystonia in normal mice, but mice that lack 
Purkinje cells do not respond to similar challenges [51–53]. Like pharmacologic challenge 
with ouabain, knockdown of the α3 isoform of the Na+/K+ ATPase within the cerebellum 
also causes dystonia in normal mice; loss of function mutations in the α3 isoform of the 
Na+/K+ ATPase cause RDP in human. Finally, conditional expression of a dystonia-causing 
genotype in only Purkinje cells also induces generalized dystonia in mice [50], suggesting 
that a single cell type may mediate the abnormal movements. Importantly, isolating the 
expression of a dystonia-causing genotype to only a small region of the cerebellum in mice 
induces focal dystonia, suggesting that focal and generalized dystonia may arise through 
shared underlying cerebellar defects [50]. Thus, work in animals has extended the studies in 
humans by demonstrating that the cerebellum can actually instigate dystonic movements.
Despite the evidence demonstrating that cerebellar dysfunction can induce dystonia, studies 
using mouse models suggest that the cerebellum does not act alone. Indeed, some studies 
suggest that combined dysfunction in the cerebellum and the basal ganglia contributes to the 
expression of dystonic movements. Striatal insults in either pharmacologically induced or 
genetic models of “cerebellar” dystonia exaggerate the dystonia [47, 48]. Further, lesions of 
the centrolateral nucleus of the thalamus, which links the cerebellum with the basal ganglia, 
ameliorate the cerebellar-induced dystonia [47], providing additional evidence that 
communication within the motor network is critical for the expression of dystonic 
movements. However, depending on the type of dystonia, the cerebellum may not be 
involved at all. For example, the basal ganglia and dopamine neurotransmission are 
associated with many dystonic disorders, such as L-DOPA-responsive dystonia, which is 
caused by defects in enzymes necessary for the synthesis of catecholamines and ameliorated 
by L-DOPA treatment. In a knock-in mouse model of L-DOPA-responsive dystonia, 
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restoration of catecholamine synthesis in the striatum via striatal L-DOPA administration 
ameliorates the dystonic movements, but administration of L-DOPA directly to the 
cerebellum is ineffective [54], demonstrating that the cerebellum is not always central to or 
even involved in the expression of dystonia. Thus, the many forms and etiologies of dystonia 
likely reflect the diversity of brain regions and biochemical defects underlying this 
heterogeneous disorder.
The Relationship Between Cerebellar Neuronal Dysfunction and Dystonia 
(Rachel Fremont and Kamran Khodakhah)
Since the 1970s, it has been appreciated that certain dystonic patients refractory to other 
treatments could benefit from surgical interventions involving the cerebellum [55]. Recent 
work corroborates this finding with studies this year showing that transcranial magnetic 
stimulation of the cerebellum and deep anterior cerebellar stimulation can improve dystonic 
symptoms [56, 57]. Therefore, while dystonia is canonically thought to be a disorder of the 
basal ganglia, there is reason to believe that in some cases the cerebellum is likely involved 
as well [58, 59]. For this reason, there has been a push to understand the neural substrates of 
cerebellar dystonia in tractable animal models.
Studies have demonstrated that electrical stimulation of the cerebellum in species from 
rodents to humans can elicit movement [60–62]. One elegant study published recently used 
optogenetics to show that the coordinated silencing of Purkinje cells was sufficient to cause 
activation of DCN neurons and elicited discrete movements in the mouse [63]. Additionally, 
the application of a number of pharmacologic agents that alter the firing of cerebellar 
neurons can elicit abnormal dystonic-like movements in rodents [47, 52]. Therefore, there is 
good evidence that under experimental conditions, the cerebellum can be driven to cause 
abnormal movements similar to dystonia in many species.
Some of the first animal studies specifically linking the cerebellum to dystonia were done in 
the DT rat, a naturally occurring autosomal recessive mutation characterized by the 
development of a progressive axial and appendicular generalized dystonia [64, 65]. 
Surprisingly, early experiments demonstrated that cerebellectomy was sufficient to 
completely alleviate dystonia in these animals whereas interventions involving the basal 
ganglia showed no benefits. Further studies demonstrated that in DT rats, both cerebellar 
Purkinje cells and projection neurons within the deep cerebellar nuclei (DCN) exhibited 
erratic and abnormal burst firing. In fact, the extent of burst firing appeared to correlate with 
severity of the symptoms.
Interestingly, the DT rat is not the only animal model of dystonia in which abnormal burst 
firing of cerebellar neurons has been implicated. It was recently shown that in both genetic 
and pharmacologic models of rapid-onset dystonia parkinsonism (RDP), abnormal bursting 
cerebellar output underlies dystonia [43, 47, 66]. Studies have shown that acute knockdown 
or pharmacologic inhibition of the α3 isoform of the sodium pump, the protein mutated in 
human RDP, converts the normally regular activity of Purkinje cells to burst firing [43, 66]. 
This erratic Purkinje cell activity in turn modifies the activity of DCN neurons, resulting in 
highly irregular cerebellar output.
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A role for cerebellum in dystonia has also been established in the tottering mice, a model of 
the human disorder episodic ataxia type 2 which, in some patients, is associated with 
dystonia in addition to ataxia [67, 68]. As noted in the prior section, studies on tottering have 
repeatedly implicated the cerebellum in the episodes of ataxia and dystonia [42, 45, 69], and 
pharmacologically normalizing the activity of cerebellar neurons can alleviate dystonic 
symptoms in these animals [70, 71]. In addition to episodic attacks of dystonia/severe ataxia, 
tottering mice also exhibit a baseline ataxia which can also be improved by medications that 
normalize the activity of cerebellar neurons [42]. Therefore, it appears that ataxia may be 
caused by irregular cerebellar output similar to what is found in cerebellar dystonia. In fact, 
in the pharmacologic model of RDP, it was shown that infusing lower concentrations of 
ouabain to the cerebellum resulted in ataxia while higher concentrations caused dystonia 
[47]. These findings suggest that ataxia and dystonia may exist on a continuum where 
modest changes in the regularity of cerebellar output may underlie ataxia while highly 
irregular firing (erratic bursting) of cerebellar output neurons underlies dystonia. Irregularity 
of cerebellar output can be quantified as the coefficient of variation of the interspike 
intervals (CV ISI) recorded from deep cerebellar nuclei (DCN) neurons. Unpublished 
studies from our lab on a large number of mouse models of ataxia and dystonia suggest that 
this is indeed the case and that the severity of motor disability increases from ataxia to 
dystonia as the irregularity of cerebellar output neurons increases (Fig. 3). Taken together, 
these studies suggest that erratic bursting of cerebellar output neurons may be a common 
mechanism by which dystonia is induced and that the degree of spiking irregularity from the 
cerebellum may dictate whether animals present with ataxia or dystonia (Fig. 3).
A recent study has provided a possible mechanism by which erratic cerebellar output may 
lead to dystonia. Chen et al. (2014) found that there is a powerful disynaptic pathway from 
the cerebellum to the striatum via the thalamus that enables the cerebellum to rapidly 
modulate the activity of the basal ganglia. Transmission of aberrant cerebellar output to the 
basal ganglia through this disynaptic pathway was found to be necessary for cerebellar-
induced dystonia and caused burst firing in the basal ganglia [35] similar to that seen in 
dystonic patients [72]. Selective disruption of this communication alleviated dystonic 
symptoms providing a potential therapeutic target for DBS [35, 47].
Overall, studies in rodents strongly suggest that highly erratic cerebellar output is likely a 
common substrate for a number of dystonias. Importantly, there is evidence from both 
imaging and lesion studies in patients that also suggest that abnormal cerebellar output is 
involved in some dystonic patients. Already, these findings have been making their way back 
to the clinic where deep brain stimulation of the cerebellum is again being considered for 
some dystonic patients. Further work addressing the prevalence of cerebellar dystonia and 
the presence of abnormal cerebellar output in patients with dystonia will be vital and will 
help guide more targeted treatment for patients with this devastating disorder.
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Relationship Between Cerebellar Neuronal Dysfunction in Animal Models 
and Human Dystonia (Mark S. LeDoux)
As noted in prior sections, isolated dystonia may be a network disorder of the CNS due to 
dysfunction at one or more nodes of the highly interconnected motor subsystem that 
includes the cerebellum and basal ganglia [3, 15]. Alternatively, dystonia may be driven by a 
single population of dysfunctional neurons and network alterations are simply downstream 
manifestations of aberrant efferent signals [64, 22]. Consensus regarding site of origin is 
lacking given that cerebellar cortex, striatum, and sensorimotor cortex have been proposed 
as loci of critical functional pathology [64, 73, 74].
To date, study of well-characterized genetic forms of dystonia has not provided convincing 
evidence in support of a cerebellar or basal ganglia origin of dystonia. Although a high 
percentage of DYT1 patients with the classic ΔGAG mutation in TOR1A respond to deep 
brain stimulation (DBS) of the internal segment of the globus pallidus (GPi), many patients 
with dystonia show little or no benefit from DBS [75–77]. Moreover, high-resolution 
metabolic maps of DYT1 dystonia in a transgenic mouse model suggest that the DYT1 
carrier state increases energy demand in the olivocerebellar network and the inferior olive 
may be a pivotal node for abnormal basal ganglia-cerebellar interactions [22]. Among the 
three main genetic causes of isolated dystonia (TOR1A, THAP1, and GNAL) [78–80], only 
GNAL shows relatively circumscribed transcription in the CNS with concentrated 
expression of its encoded protein Gα(olf) in the olfactory bulb, striatum, and cerebellar 
Purkinje cells [80–82]. Although modestly enriched in cerebellum, TOR1A and THAP1 are 
broadly expressed throughout the brain [81, 82].
Functional imaging in humans with primary dystonia and clinical-pathological correlations 
in secondary dystonia have provided evidence that dystonia may be a disorder of 
olivocerebellar pathways [82, 83]. A critical role for the cerebellum in the pathophysiology 
of dystonia [84, 85] is supported by data from a variety of clinical fronts including the lesion 
localization in secondary dystonia [86, 87], the syndrome of dystonia with cerebellar 
atrophy (DYTCA) [59], the postmortem pathology in cervical dystonia [88], and the well-
known finding that dystonia may be a presenting or prominent feature in several of the 
hereditary ataxias (SCA1, SCA2, SCA3, SCA6, etc.), although it should be noted that these 
are multisystemic diseases with degeneration that is not confined to the cerebellum.
Data from animal models also implicates olivocerebellar pathways, particularly Purkinje 
cells and cerebellar nuclear neurons, in the pathophysiology of dystonia [43, 66, 89]. For 
instance, morphologically/physiologically defective Purkinje cells or Purkinje cell loss has 
been described in tottering mice, DYT1 knock-in mice, waddles mice and dt rats [89–92]. In 
addition, virtually, all genes associated with dystonia in spontaneous mutants (tottering, 
stargazer, ophisthotonus, ducky, lethargic, waddles, and wriggle) are involved in Purkinje 
cell Ca2+ signaling (Canca1a, Cacng2, Itpr1, Cacna2d2, Cacnb4, and Pmca2). Moreover, the 
genetically dystonic rat, which exhibits a defect at the climbing fiber-Purkinje cell synapse, 
shows up-regulation of plasma membrane calcium-dependent ATPase 4 (PMCA4) in parallel 
fibers [93]. In humans, autosomal-recessive mutations in HPCA cause childhood-onset 
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dystonia and the encoded protein, hippocalcin, is robustly expressed in Purkinje cells and 
serves as a Ca2+ sensor [94, 95].
As noted in prior sections, Raike and colleagues have shown that the manifestation of 
dystonia in response to stress, caffeine, and ethanol in Canca1a mutant tottering mice can be 
isolated to abnormal Purkinje cells [96]. At high concentrations, caffeine acts at ryanodine 
receptors (RyR) to facilitate the mobilization of calcium from intracellular stores. In 
tottering mice, intracerebellar injections of ryanodine prevented paroxysms of dystonia. 
Purkinje cell dysfunction can also be presynaptic in origin given that quirky mice, in which 
Cacna1a loss is limited to cerebellar granule cells, exhibit dystonia [97]. In final analysis, 
abnormal signaling in cerebellar cortex due to dysfunction of Purkinje cells or their afferents 
(parallel and/or climbing fibers) will manifest as abnormal firing patterns of cerebellar 
nuclear neurons [64, 89, 98]. Compatible with this model, abnormalities of cerebellar 
outflow have been reported in humans and animal models of primary or isolated dystonia 
[40, 43, 66, 74, 99].
What Do Studies of Cerebellar Metabolism and Connections in Humans Tell 
Us about a Role for the Cerebellum in Dystonia? (Christian Dresel, Martin 
Niethammer, and David Eidelberg)
Studies in human subjects with dystonia suggest a role for the cerebellum in this disorder. 
Here, we review metabolic changes in the cerebellum as well as structural and functional 
connections between the cerebellum and the rest of the central nervous system in patients 
with generalized and focal dystonia.
Cerebral Metabolism and Blood Flow
[18F]-Fluorodeoxyglucose (FDG) PET studies have found increased glucose metabolism at 
rest in the cerebellum of patients with sporadic and genetic dystonias [58, 100–103]. Spatial 
covariance approaches based on principal component analysis identified a disease-specific 
pattern of regional metabolic activity, termed torsion dystonia-related pattern (TDRP) [104]. 
This pattern is characterized by relative metabolic increases in the putamen/globus pallidus, 
supplementary motor area, and cerebellum. Increased expression of TDRP appears unrelated 
to somatotopic distribution of clinical manifestations or penetrance in gene carriers of 
DYT1, though it should be noted that non-manifesting carriers of the DYT6 mutation do not 
exhibit such an increased expression pattern [105, 106].
Studies of blood flow changes with [15O]-H2O PET, which measures alterations in brain 
activity, have demonstrated abnormal activation in numerous brain regions in dystonia, 
including the cerebral cortex, basal ganglia, thalamus, and the cerebellum [107–110]. 
Moreover, non-manifesting DYT1 carriers showed compensatory cerebellar activation 
during motor sequence learning [109]. Abnormal activation of cerebellar structures has also 
been measured with functional magnetic resonance imaging (fMRI) using blood 
oxygenation level-dependent (BOLD) contrast in a number of focal dystonias [17].
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Structural and Functional Cerebellar Connectivity
Using diffusion tensor imaging (DTI) and voxel-based morphometry, MRI demonstrated 
reduced fractional anisotropy (a marker of impaired axonal integrity) and decreased gray 
matter volume in the cerebellum of patients with generalized and focal dystonia [111, 112]. 
Applying probabilistic tractography, Argyelan and colleagues identified genotype-specific 
fiber tract differences between manifesting and non-manifesting DYT1 and DYT6 mutation 
carriers [99]. Manifesting and non-manifesting carriers were found to have reduced integrity 
in their cerebellothalamic fiber tracts irrespective of clinical status, in line with earlier results 
in primary torsion dystonia [112]. Non-manifesting carriers had an additional connectivity 
abnormality in the thalamocortical segment of the cerebello-thalamo-cortical projections, 
suggesting a penetrance model in dystonia, whereby cerebellothalamic pathway disruptions 
lead to dystonia, unless counterbalanced by a second lesion downstream [99]. Indeed, these 
findings were supported by a genetic mouse model of DYT1 [40]. In a follow-up human 
study, DYT1 and DYT6 mutation carriers showed microstructural changes in the form of 
reduced fractional anisotropy in the paravermian cerebellar white matter [113]. When this 
area was used for subsequent DTI fiber tracking, patients with both inherited and sporadic 
forms of dystonia showed a 60–70 % reduction of white matter tracts passing through the 
thalamus to the leg representation in the primary sensorimotor cortex as compared to healthy 
subjects. Functionally, cerebellar pathway integrity is linked to motor activation responses. 
In manifesting and non-manifesting DYT1 and DYT6 carriers, reductions in 
cerebellothalamic connectivity correlated with reduced motor activation in the cerebellum 
and increased activation in cortical motor areas, consistent with loss of inhibition at the 
cortical level [99].
DYT1, but not DYT6 carriers, exhibited significant increases in motor sequence learning-
related activation in the left lateral cerebellar cortex and in the right premotor and inferior 
parietal regions. In these DYT1 carriers, learning-induced increases in premotor cortical 
activation correlated with reductions in cerebellar pathway integrity [108]. Genotype-
specific reductions in cerebellothalamic connectivity appeared to be smaller in carriers of the 
DYT6 relative to the DYT1 mutation [99]. We therefore hypothesized that the magnitude 
and spatial extent of this microstructural abnormality is greater in DYT1 carriers, perhaps 
accounting for learning deficits with this genotype, but not with the (clinically more 
localized) DYT6 mutation [105].
In this vein, affected DYT1 carriers were recently found to exhibit abnormal fMRI activation 
in response to the visual perception of motor [114]. In healthy individuals, the perceptual 
distinction between “natural” vs. “unnatural” motion is mediated through the right 
cerebellar, superior parietal, and temporo-occipital cortical association areas. However, the 
pattern of task-related activation was abnormal in the DYT1 subjects in association with 
microstructural changes involving ponto-cerebellar pathways. Subsequent preliminary work 
from our group has demonstrated analogous changes in affected DYT6 carriers and in 
individuals with sporadic dystonia. Irrespective of inherited trait or genotype, motion 
perception-related activation correlated with loss of microstructural integrity involving 
cerebellar outflow pathways.
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The mechanistic basis underlying these changes is not clear. Using resting-state fMRI, 
Dresel et al. found increased negative functional connectivity (FC) between several seed 
regions-of-interest of the motor cerebellum (namely crus I and II) to primary and secondary 
cortical sensorimotor areas in patients with sporadic writer’s cramp [115]. The (absolute) 
magnitude of FC was inversely correlated with duration and severity of disease. This finding 
was unexpected and raised the question if stronger cerebellocortical coupling in affected 
patients could be a compensatory mechanism as suggested by the studies of metabolism and 
motor learning. A decline of this increased FC might then be interpreted as progressive 
failure of such compensation in patients with longer or more severe disease.
In summary, imaging studies in human dystonia subjects have revealed changes in resting 
cerebellar metabolism, as well as reduced microstructural integrity and functional 
connectivity in cerebello-thalamo-cortical projection pathways. It is unclear whether these 
changes reflect underlying cerebellar pathology, a compensatory mechanism, or a 
combination of the two effects. Quantitative measures of structural connectivity suggest that 
hereditary dystonias may have a neurodevelopmental origin, whereby disruptions in 
cerebellothalamic fiber tracts lead to the development of symptoms unless associated with a 
second downstream lesion in thalamocortical pathways.
What Do fMRI and VBM Studies Tell Us about a Role for the Cerebellum in 
Dystonia? (Traian Popa, Cécile Gallea, and Stéphane Lehericy)
Imaging studies, whether structural using voxel-based morphometry (VBM) and diffusion 
imaging or functional using fMRI and PET, have repeatedly reported evidence of cerebellar 
abnormalities in human primary dystonia. Structural changes within the brain are present at 
various levels of the sensorimotor network. Using structural neuroimaging techniques, such 
as VBM and diffusion tensor imaging, grey matter increase or decrease and white matter 
changes were observed in primary dystonias in the sensorimotor, premotor, and parietal 
cortex, the basal ganglia, the thalamus, and the cerebellum. Cerebellar changes were 
reported in sporadic forms including non-task specific cervical dystonia and blepharospasm 
[116–118], task-specific laryngeal dystonia, and writer’s cramp [118], as well as inherited 
forms [99, 119]. Using diffusion imaging, white matter changes were also observed in the 
cerebellum of sporadic dystonia [118]and the cerebello-thalamo-cortical fiber tract in 
DYT1-6 dystonia [99, 113]. Changes varied between studies and types of dystonia, and so 
far, it is not precisely known whether these variations are due to the type of dystonia or to 
technical differences between studies. However, as noted in the previous section, changes in 
the cerebello-thalamic fiber tract may be common to patients with inherited and sporadic 
dystonias, whereas changes in the thalamo-cortical fiber tract may only be observed in non-
manifesting carriers or in non-affected regions of patients with sporadic dystonia [113].
Functional MRI has shown changes that mirrored the structural changes at the level of the 
basal ganglia, the motor-related cortical regions as well as the cerebellum [118, 120]. In the 
cerebellum, abnormal activation during performance of various sensorimotor tasks has been 
reported using fMRI in blepharospasm [121–123] and writer’s cramp [124, 125] and 
using 15H20 PET in patients with DYT1 and DYT6 mutations [108]. Abnormal cerebellar 
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involvement related to proprioceptive drift during the rubber hand illusion was also observed 
in focal hand dystonia [126]. In patients with focal hand dystonia, reduced interactions 
between the striato-cortical and cerebello-cortical networks have also been reported with 
reduced communication between the striatum and the cerebellum [125, 127].
Using fMRI at rest, a functional connectivity decrease is frequently found among many 
motor regions of patients with focal hand dystonia. This decrease was found between the 
parietal and dorsal premotor areas [128], in the left postcentral areas [129], and between the 
affected sensorimotor cortex and the basal ganglia and premotor cortex and prefrontal 
cortex, which correlated with disease severity [115]. In the cerebellum, a stronger negative 
functional connectivity of cerebellar structures to primary and secondary sensorimotor areas 
was found in some [115] but not all studies [128].
Imaging studies are limited in some ways because often they do not allow determining 
whether the observed structural changes are the cause or the consequence of the disease and 
because knowledge of the pathological correlates of imaging data is poor [130]. In spite of 
these limitations, imaging results provide overall converging evidence from structural and 
functional techniques that the cerebellum is implicated in the pathophysiology of various 
types of dystonia. They also suggest that not only nodes (i.e., brain regions) in the 
sensorimotor network but also communications between them are abnormal, in line with the 
view that dystonia is a network disorder. Indeed, the cerebellum and the basal ganglia are 
able to interact at various levels of the sensorimotor network as described above. In the 
cortex, physiological studies have shown that the cerebellum was able to dynamically 
modulate sensorimotor plasticity in healthy subjects by gating peripheral inputs [131]. This 
gating does not exist anymore in dystonic patients [132]. Impairment of the cerebellar 
outflow to the cortex is supported by neuroimaging studies of fiber integrity in dystonic 
patients [99, 105, 114]. Anatomically, the existence of a disynaptic connection between the 
basal ganglia and the cerebellum is another route where the two networks may interact [34, 
133, 134]. It is possible that disturbance in any part of the cortico-striatal and cortico-
cerebellar circuits would lead to functional imbalances and also trigger compensatory 
activity in the remaining circuits. Abnormal communication between the nodes would result 
in a lack of control of the motor output.
Changes in specific nodes and abnormal functional interactions between these nodes may 
contribute differently to the various forms of dystonia. In task-specific dystonia such as 
writer’s cramp which is associated with intensive practice and overuse of a particular group 
of synergistic muscles, the loss of interaction between the cerebellar and striatal networks 
during learning [125, 127] might contribute to impaired information transfer and thus to the 
acquisition of an abnormal sensorimotor representations. In contrast, in genetic dystonia, 
cerebellar activation during motor sequence learning may be compensatory [108]. The 
cerebellum could play a role in sensory deficits in focal hand dystonia [135], as suggested by 
the abnormal cerebellar involvement reported during sensory processing in these patients 
[126]. This hypothesis is further supported by the fact that the cerebellum exerts powerful 
influences over the somatosensory system and receives direct somatosensory input from the 
spinal cord [136, 137]. Further studies will determine whether there is a pathophysiological 
substrate common to all forms of dystonias or whether changes in specific nodes and 
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circuits, and abnormal functional interactions between these nodes contribute differently to 
the various forms of dystonia.
What Does Brain Structure in Human Dystonia Tell Us about a Role for the 
Cerebellum? (Amit Batla, Kailash P Bhatia)
We examine here, the clues from the understanding of brain structure and its abnormalities 
and what this tell us about a role for the cerebellum in human dystonia.
a. Evidence from cerebellar changes observed in clinical practice and using clinical 
neuroimaging
i. Cerebellar atrophy with or without cerebellar signs has been recognized on 
routine neuroimaging in patients with dystonia [59, 86]. In one study, 9 % of 
patients with segmental and cervical dystonia were found to have cerebellar 
atrophy [138]. The spinocerebellar ataxias (SCA) are known to have structural 
atrophy and degeneration of the cerebellum. Dystonia may be a presenting 
clinical feature of SCA [138] with up to 9 % of SCA2 patients reported to have 
dystonia at presentation [139, 140]. SCA17, SCA3, and other SCAs [141] are 
also commonly associated with dystonia. Two clinical case series [142, 143] 
have been reported under the rubric “the syndrome of (predominantly cervical) 
dystonia and cerebellar ataxia (DYTCA)” [142, 143].
ii. Lesions of cerebellum in patients with dystonia. Some case reports [144] and 
small series [86] have reported cerebellar lesions in patients with dystonia. More 
recently, a clinical study of 188 patients described clinically overt lesions of 
cerebellum in 5% of cases with cervical/segmental dystonia [138].
The clinical association of dystonia with cerebellar lesions, atrophy, and inherited ataxias 
supports the role of cerebellum and its connections in a small proportion of patient with 
dystonia; however, such evidence needs to be interpreted carefully and causality cannot be 
assumed from these results [130].
b. Evidence from structural changes observed using advanced neuroimaging
As noted in the prior section, imaging in primary dystonia (DYT-1) using voxel-based 
morphometry (VBM) has demonstrated abnormalities in cerebellum and its connections 
with lenticular nucleus and supplementary motor area [117]. In cases with focal dystonia, 
VBM studies have shown structural grey matter abnormalities in the cerebellum in patients 
with upper limb dystonia [111], cervical dystonia [116, 117], and blepharospasm [117]. In 
cases with primary generalized dystonia, diffusion tensor imaging (DTI) has been used to 
study microstructural changes deduced through fractional anisotropy (FA) [112]. In DYT 11 
patients and carriers, microstructural abnormalities have been demonstrated using DTI in the 
vicinity of cerebellar peduncles. Similarly in patients with DYT-1 and DYT-6 genetic 
mutations, diffusion tractography showed reduced connectivity of the cerebellum with the 
thalamus [99]. These changes are however not exclusive to the cerebellum but also affect the 
basal ganglia, thalamus, and frontal lobes [130]. Based on these observations, it has been 
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suggested that loss of inhibition at the cortical level consistent with a loss of cerebellar 
inhibitory outflow may be present in patients with dystonia [99, 130].
c. Evidence of structural involvement of cerebellum derived from neurophysiology
Physiologically, dystonia has been suggested as a result of changes to defects in neural 
inhibitory processes, sensorimotor integration, or neural plasticity. The cerebellum and more 
specifically the connections between inferior olive and the deep cerebellar nuclei can be 
studied using eyeblink conditioning (EBC). Abnormalities in EBC have been shown in 
primary focal dystonia [145], but not in patients with DYT1 and DYT6 dystonia [15]. 
Patients with basal ganglia dysfunction such as Parkinson’s disease are expected to have 
normal EBC [146]. Thus, abnormalities in this paradigm support the idea that other 
structures such as cerebellar nuclei may be involved.
d. Directly observed structural abnormalities of the cerebellum on pathology
Patchy loss of Purkinje cells, areas of focal gliosis, and torpedo bodies have been seen in the 
cerebellum in patients with cervical dystonia [88, 111]. A bilateral increase in the gray 
matter volume of cerebellar flocculus was seen in patients with cervical dystonia [116], and 
bilateral structural abnormalities in the sensorimotor territory of the cerebellum were 
observed in patients with focal hand dystonia [111]. In primary generalized dystonia, 
Purkinje cell loss has been seen in DYT1 patients [147]. Mild to moderate cell loss in 
dentate nucleus has been seen in a case with Meige’s syndrome [148] but not in DYT6, and 
other cases with pure primary dystonia [149]. It is however interesting to note that TorsinA 
(the protein product affected in DYT 1 mutations) is widely distributed throughout the 
central nervous system in humans including cerebellar Purkinje cells and Dentate nucleus 
[149].
In summary, evidence supports that cerebellar atrophy, cerebellar degenerative disease, 
cerebellar lesions, and microstructural changes in cerebellum can be associated with 
dystonia. This is further confirmed by pathological studies demonstrating cerebellar changes 
in dystonia. Neurophysiological changes in dystonia support the role of a “network model” 
that accommodates neuropathological and neuroimaging evidence that dystonia may be 
associated with abnormalities in multiple brain regions including cerebellum [3]. From the 
current understanding, it seems plausible that dystonia may result from a disorder that 
affects the basal ganglia, cerebellum, or their connections through the thalamus or directly 
with the motor or premotor cortex. The evidence however needs to be examined critically, 
and although cerebellum may contribute significantly to the subcortical network abnormality 
leading to dystonia, causal association is far from established [130] and further studies are 
needed.
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Noninvasive (Transcranial Magnetic (TMS) and Transcranial Direct Current 
(tDCS)) Stimulation Studies of the Cerebellum in Dystonia (Sabine Meunier 
and Mark Hallett)
Noninvasive modulation of cerebellar activity in humans can help understand a role for the 
cerebellum in motor control. Here, we examine what cerebellar stimulation studies tell us 
about a role for the cerebellum in dystonia.
Instantaneous Change: Dual Site Single Pulse TMS: the CBI Paradigm
In healthy subjects, a single TMS shock to the posterior cerebellum on one side inhibits the 
test MEP evoked by a single TMS shock to the contralateral primary motor cortex (M1). 
Inhibition occurs when the test shock follows the cerebellar shock by 5 to 7 ms [150]. The 
MEP inhibition is referred to as “cerebellar-brain-inhibition” (CBI). The cerebellar shock 
likely activates the Purkinje cells inducing an inhibition of the dentate nucleus and a de-
facilitation of the excitatory dentato-thalamo-cortical pathway. CBI was decreased on both 
affected and non-affected side of patients with focal hand dystonia compared to healthy 
volunteers [151]. The bilateral distribution despite unilateral symptoms suggested a bilateral 
involvement of the cerebellar cortex and/or the efferent cerebellar pathways that maybe an 
endophenotype of the disease. This finding has not been replicated so far; the CBI was found 
normal in groups of cervical dystonia patients [152] and focal hand dystonia patients. In this 
latter group, despite normal mean CBI level, greater CBI was associated with worse hand 
function [56].
Enduring Change of Cerebellar Excitability
Plasticity-inducing protocols using TMS (1 Hz or theta burst rTMS) or tDCS can be used to 
induce lasting (in the range of the hour) changes of excitability of the cerebellar cortex.
Cerebellum Modulation of M1 Plasticity—In healthy subjects, excitation of the 
cerebellar cortex by intermittent theta burst rTMS (iTBS) prevents the development of a 
subsequent associative plasticity (induced by paired associative stimulation, PAS) in M1. 
Inhibition of the cerebellar cortex by continuous theta burst rTMS (cTBS) enhances 
subsequent M1 plasticity, along with spread to the motor representations of adjacent muscles 
in M1 [131]. Both anodal and cathodal tDCS to the cerebellum prevent the development of a 
concurrent PAS-induced plasticity in M1 [153]. Converging arguments indicate that 
modulation of associative cortical plasticity is not exerted through a direct effect on the 
cerebello-cortical output, but instead through local changes of cerebellar excitability that 
impact the cerebellar processing of afferent volleys involved in the PAS-induced effects 
[131, 153].
In patients with writer’s cramp, iTBS and cTBS to the cerebellum both failed to influence 
the subsequent development of PAS-induced plasticity [132]. This suggests that the inability 
of the cerebellum to adequately process the incoming sensory afferent volleys may lead it to 
send an erroneous message to M1 and de facto causes a cerebellum-M1 functional 
decoupling. These group results have been questioned (1) as the high variability in the 
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individual responses to PAS may cause an overlap between the plastic responses of patients 
and healthy volunteers and (2) because anodal cerebellar stimulation was found to retain its 
ability to reduce the PAS-induced plasticity in a sub group of writer’s cramp patients 
selected for having significant plastic responses after PAS [154].
More studies with a detailed screening of the distribution of the PAS responses in the control 
and patient groups are needed to reach the conclusion that the lack of cerebellar control onto 
the development of sensorimotor plasticity in M1 is a physiological hallmark of dystonia.
Cerebellar Modulation of Motor Adaptation Tasks—At the behavioral level, the use 
of cerebellar stimulation has confirmed that the cerebellum plays a role in the abnormal 
sensorimotor adaptation documented in dystonia [145, 155]. The capacity for online 
adjustment to a visuo-motor conflict (that involves the cerebellum) and the capacity for 
washing out an earlier adaptation were predictors of the extent of cerebellum-induced 
changes of M1 plasticity, but not of the extent of the plastic responsiveness of M1 by itself 
[132].
Acquisition of eye blink classical conditioning (EBCC), a cerebellar-dependent form of 
associative motor learning that depends on the integrity of the olivo-cerbellar circuit, was 
impaired in patients with writer’s cramp or cervical dystonia [145]. Cerebellar cTBS 
normalized the EBCC in patients with cervical dystonia [156] while it disrupted it in healthy 
volunteers [157].
The results of the behavioral and EBCC studies confirm that abnormal encoding of motor 
memories in dystonia relies on phenomena occurring upstream from M1, likely, at least in 
part, in the cerebellum. They also raise the possibility that disruption of the cerebellum in 
dystonia may be reversible.
Therapeutics of Focal Dystonia by Cerebellum Stimulation
A blind randomized controlled study has shown a modest beneficial effect of 2 weeks 
sessions of cTBS to cerebellum in cervical dystonia patients [152]. Indeed, 2 weeks of 
stimulation led to a transient (less than 2 weeks) decrease of 15% of the TWSTRS scale. 
This clinical effect was paralleled by neurophysiological effects including effects on the 
PAS-induced plasticity and the CBI that both showed a trend to be back to the normal 
pattern as observed in controls.
One session of cTBS to cerebellum failed to improve the writing performances of writer’s 
cramp patients [158]. One session of anodal tDCS was reported to improve the kinematics of 
handwriting (reduced mean stroke frequency and average pen pressure and increased writing 
speed) in 8 people with focal hand dystonia [56] while there was no effect on the WCRS and 
investigator or self-rated assessment of handwriting speed [154]. No study so far has looked 
at the effects of repeated sessions of TBS to cerebellum in focal hand dystonia.
Taken together, the data showing various abnormalities in different types of dystonia in 
response to various paradigms involving the cerebellum are strong. Moreover, the possible 
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improvement in dystonic symptoms with cerebellar modulation raises a possible new 
approach to therapy of these patients.
Consensus Summary
Rodent Studies
• Abnormal motor activity resembling human dystonia can be produced in rodents.
• In many rodent models, dystonia results from abnormalities in cerebellar cortical 
activity and subsequent abnormalities in cerebellar output.
• In rodent dystonia models, an alteration in cerebellar output correlates with 
abnormal and sustained muscle contraction.
• Eliminating cerebellar output abolishes the generalized dystonia in some rodent 
models of dystonia, suggesting that the cerebellum is a critical node in the 
pathway leading to the expression of dystonia.
Human Studies
• Healthy human subjects exhibit the phenomenon of “cerebellar-brain-inhibition” 
(CBI) in response to TMS shock to the posterior cerebellum. Excitation of the 
cerebellar cortex by iTBS prevents the development of a subsequent associative 
plasticity in the motor cortex, while inhibition of the cerebellar cortex by 
continuous theta burst cTBS enhances subsequent motor cortex plasticity. These 
data suggest that under these conditions, the cerebellum is capable of directly 
modulating motor activity. These physiological mechanisms appear to be 
abnormal in patients with dystonia revealing cerebellar abnormality in the 
pathophysiology.
• In subjects with some forms of dystonia acquisition of eye blink classical 
conditioning (EBCC), a cerebellar-cortex dependent form of associative motor 
learning is impaired.
• Diffusion tensor imaging (DTI) and voxel-based morphometry demonstrate 
reduced fractional anisotropy (a marker of impaired axonal integrity) and 
decreased gray matter volume in the cerebellum of some patients with 
generalized and focal dystonia.
• In subjects with some inherited forms of generalized dystonia, manifesting and 
non-manifesting carriers have reduced fiber tract integrity in their 
cerebellothalamic tract as assessed by DTI. Non-manifesting carriers had an 
additional abnormality in thalamocortical connectivity.
• In some studies, using fMRI, increased resting state functional connectivity was 
found between the cerebellum and sensorimotor areas.
• PET imaging demonstrates abnormal cerebellar activity and metabolism in 
several different forms of dystonia.
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• Structural defects of the cerebellum including atrophy, and lesions are associated 
with dystonia.
Consensus Opinions for Future Research
• Abnormal cerebellar activity in rodents causes sustained muscle contractions 
producing maintained postures similar to human dystonia.
• The cerebellum can act as a primary node for the causation of dystonia in rodent 
models.
• Data from human studies demonstrate an association between cerebellar 
abnormalities and dystonia. However, it is not yet clear whether the role of the 
cerebellum is causal, contributory, or compensatory.
• Future studies should be designed to differentiate a primary causal role for the 
cerebellum in dystonia from compensatory and contributory effects. Studies 
needed to prove causation of the cerebellum in dystonia in humans will likely be 
difficult.
• The identification of the cerebellum as a potential node in dystonia is important 
in order to determine whether interventions directed towards the cerebellum may 
be a treatment modality for dystonia. Future studies continuing to explore the 
role for the cerebellum in dystonia are therefore important.
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Fig. 1. 
The role of animal models in exploring the pathogenesis and treatment of human disorders. 
a An experimental question about the human disorder can be explored in animal models. 
The relevance of the result from the animal model must ultimately be confirmed in humans. 
b In some cases, an experimental question about a human disorder can be explored in a 
simple animal model, such as a rodent. Results from the simple model can be explored 
further in non-human primates before confirming in humans
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Fig. 2. 
Cerebellar connections with the basal ganglia. Schematic representation of the anatomical 
connections between the cerebellum and basal ganglia in non-human primates. Based on 
[34] and [36]. DN dentate nucleus, GPe external segment of the globus pallidus, GPi internal 
segment of the globus pallidus, PN pons, STN subthalamic nucleus
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Fig. 3. 
Schematic of the proposed relationship between locomotor disability and irregularity of 
cerebellar output in mouse models. A proposed relationship between locomotor disability 
and irregularity of cerebellar output in mouse models described as having ataxia and/or 
dystonia. Here, locomotor disability is quantified based on a previously published dyskinesia 
scale that incorporates symptoms consistent with ataxia and dystonia. As the severity on the 
dyskinesia scale increases, the motor phenotype transitions from ataxia to dystonia. 
Irregularity of cerebellar output can be quantified as the coefficient of variation of the 
interspike intervals (CV ISI) recorded from deep cerebellar nuclei (DCN) neurons. This 
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value takes into account both the standard deviation of the interspike intervals and the 
average firing rate of the cell. Under normal conditions, the dyskinesia score is low as is the 
CV ISI for DCN cells (black dot). We propose that there may be a monotonic relationship 
between disability and irregular cerebellar output such that as cerebellar output becomes 
more erratic, the disability of the animal increases (gray line). In this scenario, mice 
exhibiting only mildly irregular DCN output would have symptoms consistent with ataxia 
(red oval) while mice with more erratic bursting activity would have symptoms more 
consistent with dystonia (blue oval)
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